/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Altimmune Inc Share Price Today: Live Updates & Key Insights

Altimmune Inc share price today is $2.82, up -2.46%. The stock opened at $2.84 against the previous close of $2.84, with an intraday high of $2.84 and low of $2.7603.

Altimmune Inc Share Price Chart

style
pb-0

Altimmune Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Altimmune Inc Share Price Performance

$2.82 -0.0246(-2.46%) ALT at 27 Jul 2026 01:55 PM Biotechnology
Lowest Today 2.7603
Highest Today 2.84
Today’s Open 2.84
Prev. Close 2.84
52 Week High 6.44
52 Week Low 2.56
Day’s Range: Low 2.7603 High 2.84
52-Week Range: Low 2.56 High 6.44
1 day return -
1 Week return -1.42
1 month return -2.47
3 month return -1.25
6 month return -51.15
1 year return -31.59
3 year return -9.21
5 year return -69.6
10 year return -

Altimmune Inc Institutional Holdings

BlackRock Inc 6.58

Vanguard Group Inc 4.88

State Street® SPDR® S&P® Biotech ETF 4.15

State Street Corp 3.67

Vanguard Total Stock Mkt Idx Inv 2.96

Vanguard Capital Management, LLC 2.91

Vanguard Portfolio Management, LLC 2.77

iShares Russell 2000 ETF 2.67

Marshall Wace Asset Management Ltd 2.07

Millennium Management LLC 1.68

Geode Capital Management, LLC 1.60

Alyeska Investment Group, L.P. 1.36

Two Sigma Investments LLC 1.27

Nuveen, LLC 1.20

Vanguard Institutional Extnd Mkt Idx Tr 1.15

Nuveen Quant Small Cap Equity R6 0.97

iShares Russell 2000 Value ETF 0.95

Vanguard Strategic Equity Inv 0.94

The Goldman Sachs Group Inc 0.69

Susquehanna International Group, LLP 0.68

iShares Biotechnology ETF 0.67

Fidelity Small Cap Index 0.66

Vanguard Explorer Inv 0.62

Vanguard Russell 2000 ETF 0.59

State St Russell Sm/Mid Cp® Indx SL Cl I 0.55

Dimensional Fund Advisors, Inc. 0.54

BlackRock Advantage Small Cap Core Instl 0.54

Northern Trust Corp 0.51

Fidelity Extended Market Index 0.51

UBS Group AG 0.47

Vanguard Fiduciary Trust Co 0.45

Russell 2000 Equity Index Fund B 0.42

Russell 2000 Index Non-Lendable Fund 0.42

Two Sigma Advisers, LLC 0.41

Morgan Stanley - Brokerage Accounts 0.40

State St Russell Sm Cap® Idx SL Cl I 0.38

D. E. Shaw & Co LP 0.37

iShares Micro-Cap ETF 0.34

International Biotechnology Ord 0.34

Fidelity Enhanced Small Cap Core ETF 0.33

Altimmune Inc Market Status

Strong Buy: 5

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Altimmune Inc Fundamentals

Market Cap 546.47 M

PB Ratio 1.9277

PE Ratio 0.0

Enterprise Value 250.78 M

Total Assets 279.93 M

Volume 1911556

Altimmune Inc Company Financials

Annual Revenue FY23:279000 0.3M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Profit FY23:null 0.0M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Net worth FY23:-78466000 -78.5M, FY22:-84713000 -84.7M, FY21:-96171311 -96.2M, FY20:-49044477 -49.0M, FY19:-20520131 -20.5M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:5000 0.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M

Quarterly Profit Q1/2026:-23000 -0.0M, Q3/2025:-14955000 -15.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M

Quarterly Net worth Q1/2026:-22563000 -22.6M, Q3/2025:-19014000 -19.0M, Q2/2025:-22146000 -22.1M, Q1/2025:-19575000 -19.6M, Q3/2024:-22845000 -22.8M

About Altimmune Inc & investment objective

Company Information Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Organisation Biotechnology

Employees 57

Industry Biotechnology

CEO Mr. Jerome Benedict Durso

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Altimmune Inc FAQs

What is the share price of Altimmune Inc today?

The current share price of Altimmune Inc is $2.82.

Can I buy Altimmune Inc shares in India?

Yes, Indian investors can buy Altimmune Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Altimmune Inc shares in India?

You can easily invest in Altimmune Inc shares from India by:

Can I buy fractional shares of Altimmune Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Altimmune Inc?

Altimmune Inc has a market cap of $546.47 M.

In which sector does Altimmune Inc belong?

Altimmune Inc operates in the Biotechnology sector.

What documents are required to invest in Altimmune Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Altimmune Inc?

The PE ratio of Altimmune Inc is N/A and the PB ratio is 1.93.